Another Example of Devastating Complication of Heparin-Induced Thrombocytopenia Post-Cardiac Surgery: Is Danaparoid the Culprit of Another Near Fatal Complication?

François Béïque, Donald Hickey, Karine Toledano, Jean-Francois Morin

.

DOI: 10.4236/ijcm.2010.12014                

Abstract

We describe a patient who developed catastrophic consequences of heparin-induced thrombocytopenia (HIT) post car¬diac surgery, for which she required reoperation using CPB. We also illustrate the impact of intraoperative transe¬sophageal echocardiography (TEE) in the surgical management of this patient.

Keywords

Danaparoid, Heparin-Induced Thrombocytopenia, Stroke, Emboli

Conflicts of Interest

The authors declare no conflicts of interest.

References

[1]	H. N Magnani, Beijering RJR, ten Cate JW, et al. “Or?garan anticoagulation for cardiopulmonary bypass in pa?tients with heparin-induced thrombocytopenia,” In: Pi?farre R, Ed., New anticoagulants for the cardiovascular patients. Philadelphia: Hanley & Belfus, 1997, pp. 487-500.
[2]	G. Gordon, H. Rastegar and R. Schumann, et al. “Suc?cessful Use of Bivalirudin for Cardiopulmonary Bypass in a Patient with Heparin-Induced Thrombocytopenia,” Journal Cardiothorac and Vasc Anesthesia, Vol. 17, 2003, pp. 632-635.
[3]	A. Koster, B. Spiess and D. Chew, “Effectiveness of Bivalirudin as a Replacement for Heparin During Car?diopulmonary Bypass in Patients Undergoing Coronary Artery Bypass grafting,” American Journal of Cardiology, Vol. 93, 2004. pp. 356-359.
[4]	A. Davis, R. Anderson and D Short, et al, “Favourable Outcome With Bivalirudin Anticoagulation During Car?diopulmonary Bypass,” The Annals of Thoracic Surgery,Vol. 75, 2003, pp. 264-265.
[5]	M. Carrier, D. Robitaille and L. Perrault, et al., “Heparin versus danaparoid in off-pump coronary bypass grafting: Results of a prospective randomized clinical trial,” Jour?nal of Thoracic Cardiovasc Surgery, Vol. 125, 2003, pp. 325-329.